Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID 36C25019F0648· VHA· 250-NETWORK CONTRACT OFFICE 10 (36C250)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $59,789 net obligations· UEI DKCXLGANZAN3· CT

Description

12 VIALS ECULAZUMAB (SOLIRIS) INJ. 10MG/ML

First action · last action
2019-01-23 · 2019-03-27
Transactions
2
First transaction's obligation
$58,836
Base + all options value (sum of deltas)
$59,789
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0355
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$59,789$0Base award · 2019-01-23 · this action $58,836 · running total $58,836Modification P00001 · 2019-03-27 · this action $953 · running total $59,789
  • Base2019-01-23+$58,836= $58,836
  • Mod P000012019-03-27+$953= $59,789
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-01-23+$58,836$58,83612 VIALS ECULAZUMAB (SOLIRIS) INJ. 10MG/ML
Mod P00001· CHANGE ORDER2019-03-27+$953$59,78912 VIALS ECULAZUMAB (SOLIRIS) INJ. 10MG/ML

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024

Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25026P0991ASD SPECIALTY HEALTHCARE, LLC250-NETWORK CONTRACT OFFICE 10 (36C250)$43,680FY2026
36C25026F0668COSETTE PHARMACEUTICALS, INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$10,398FY2026
36C25026N0655PROGENICS PHARMACEUTICALS INC250-NETWORK CONTRACT OFFICE 10 (36C250)$721,744FY2026
36C25026N0616AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$37,180FY2026
36C25026D0061AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25019F0648_3600_36F79718D0355_3600 · retrieved 2026-09-26.